Treatment of Occult Hepatitis C Virus Infection: Does It Need Special Attention?

Rezaee-Zavareh, Mohammad Saeid; Einollahi, Behzad
July 2014
Hepatitis Monthly;Jul2014, Vol. 14 Issue 7, p1
Academic Journal
Letter to the Editor
A letter to the editor is presented in response of the article "Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013" by N. Ebrahimi Daryani, S. M. Alavian and colleagues, published in 2013 issue.


Related Articles

  • Treating Hepatitis C in Patients with Renal Failure. Lens, Sabela; Rodriguez-Tajes, Sergio; Llovet, Laura-Patricia; Maduell, Francisco; LondoƱo, Maria-Carlota // Digestive Diseases;May2017, Vol. 35 Issue 4, p339 

    Background: There is a strong relationship between hepatitis C virus (HCV) infection and the kidney. Approximately 10-16% of the patients with HCV infection develop renal disease, and the prevalence of HCV infection in patients with renal dysfunction is higher than that of the general population...

  • The Comparision of Hepatitis C Virus (HCV) Core Antigen and HCV RNA Levels for Diagnosis of HCV Infection in Haemodialysis Patients. Kizilates, Filiz; Cekin, Yesim; Sari, Funda; Sarikaya, Metin; Seyman, Derya; Oztoprak, Nefise; Cetinkaya, Ramazan // HealthMed;2013, Vol. 7 Issue 8, p2395 

    The diagnosis and monitoring of HCV infection are commonly based on anti-HCV assays. But anti-HCV assays indicate only the exposure of virus therefore confirmation with nucleic acid amplification assays is supposed. Architect HCV Ag assay is recently developed for detecting HCV nucleocapsid...

  • Prevalence of Hepatitis C Virus Infection in Different Population Groups in Southern Italy. Montella, M.; Crispo, A.; Grimaldi, M.; Angeletti, C.; Amore, A.; Ronga, D.; Sabbatici, M.; Pisani, A.; Spiteri, D.; Serraino, D. // Infection;Feb2005, Vol. 33 Issue 1, p9 

    Background: A cross-sectional. investigation was carried out between 2000 and 2002 to assess the prevalence of hepatitis C virus infection (HCV) in Naples, southern Italy. Patients and Methods: Five groups of individuals were investigated, two at low risk and three at high risk for HCV...

  • AlphaIFN Clearance Reduced in HD Patients.  // Kidney;Jul/Aug99, Vol. 8 Issue 4, p173 

    Studies the pharmacokinetics of alpha-interferon-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function. Mean maximum serum alpha-interferon concentration; Quantification of the impact of renal failure on alpha-interferon pharmacokinetics.

  • Pegylated Interferon With or Without Ribavirin for Patients With Hepatitis C Receiving Hemodialysis.  // Annals of Internal Medicine;12/3/2013, Vol. 159 Issue 11, pI-14 

    The article reports on a study to examine the efficacy of ribavirin to pegylated interferon-alpha2a therapy in case of patients with hepatitis C virus genotype 1 receiving hemodialysis. The study was carried on patients with chronic hepatitis C who were receiving hemodialysis for end-stage renal...

  • Recent Progress in the Development of Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Koch, Uwe; Narjes, Frank // Current Topics in Medicinal Chemistry;Jul2007, Vol. 7 Issue 13, p1302 

    The global prevalence of hepatitis C virus (HCV) infection and the serious consequences associated with the chronic state of the disease have become a worldwide health problem. A combination therapy comprising Interferon-alpha and Ribavirin represents the current standard treatment for chronic...

  • Utility of routine real time quantitative PCR monitoring of HCV infection in haemodialysis patients. Datta, S.; Goel, N.; Wattal, C. // Indian Journal of Medical Microbiology;2015 Supplement 1, Vol. 33, pS106 

    Background: Hepatitis C virus (HCV) infection causes significant morbidity and mortality in patients of end stage renal disease (ESRD) on haemodialysis (HD). Stringent screening methods can help in its early diagnosis. Objective: The study addresses the utility of real-time quantitative...

  • Next Generation Sequencing-Based Investigation of Potential Patient-to-Patient Hepatitis C Virus Transmission during Hemodialytic Treatment. Zhao, Qi; Wen, Yujie; Jiang, Yan; Zhang, Chen; Li, Yang; Zhang, Guiyun; Zhang, Lei; Qiu, Maofeng // PLoS ONE;1/25/2016, Vol. 11 Issue 1, p1 

    We investigated potential patient-to-patient transmission of hepatitis C virus (HCV) in two hemodialysis centers in Beijing, China. Approximately 8.25% (32/388) hemodialysis patients were HCV antibody positive, and 4.90% (19/388) were HCV RNA-positive, which consisted of 2a genotype (1/19) and...

  • Anti-Viral Therapies for Hepatitis C Virus Infection: Current Options and Evolving Candidate Drugs. Fanning, Liam J. // Letters in Drug Design & Discovery;Mar2005, Vol. 2 Issue 2, p150 

    Chronic hepatitis C is a ubiquitous disease, affecting approximately 170 million globally. The hepatitis C virus (HCV) is spread by parenteral transmission of body fluids, primarily blood or blood products. The hepatitis C viral genome is a positive-sense, single-stranded RNA molecule...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics